

Netmeds First Membership
Quick Links
Introduction About JALRA-M 50/500 MG TABLET
The Jalra-M 50/500 Tablet is a combination medication containing Vildagliptin (50 mg) and Metformin (500 mg), designed for effective blood sugar control in adults with type 2 diabetes. It helps improve glycemic control while minimizing side effects.
Jalra-M 50/500 Tablet works by making your pancreas secrete more insulin, a hormone used to digest glucose and makes your body cells efficiently utilise circulating blood sugars.
Take Jalra-M 50/500 Tablet with meals once or twice daily as directed by your doctor. Your doctor will decide the correct dose of the medicine based on its effects in controlling your blood sugar. Try to take the medicine at the same time each day to have optimum levels of medicine in the blood to have better control on blood sugar throughout the day.
Before taking Jalra-M 50/500 Tablet inform your doctor if you have any liver, kidney or heart problems or if you are pregnant or breastfeeding as a precaution. The most common side effects of taking jalra-M 50/500 Tablet are nausea, vomiting, abdominal discomfort, dyspepsia, indigestion, headache and dizziness. Consult your doctor if any of these side effects trouble you.
Key Composition
The active ingredients present in Jalra-M 50/500 Tablet are:
- Metformin: A Biguanide
- Vildagliptin: A Dipeptidyl peptidase-4 (DPP-4) inhibitor.
Uses Of JALRA-M 50/500 MG TABLET
- Helps manage blood sugar levels in type 2 diabetes.
- Improves insulin sensitivity and reduces glucose production in the liver.
Benefits of JALRA-M 50/500 MG TABLET
1. Jalra-M for blood sugar control:
Jalra-M contains Vildagliptin and Metformin, which work together to effectively control blood sugar levels. Vildagliptin improves insulin sensitivity, while Metformin reduces the amount of sugar produced by the liver, helping maintain stable blood glucose levels.
2. Reduces Insulin Resistance:
The combination of Vildagliptin and Metformin enhances the body's response to insulin, making it effective in lowering insulin resistance, which is a key factor in Type 2 Diabetes.3. Weight Management Support:
Unlike some other diabetes medications, Jalra-M is weight-neutral, which means it does not cause weight gain. In some cases, it may even assist in modest weight loss, making it beneficial for those with Type 2 Diabetes who need to manage their weight.4. Decreases the Risk of Hypoglycemia:
Jalra-M has a lower risk of causing hypoglycemia (low blood sugar) compared to some other diabetes medications, especially when used alone or in combination with other agents like diet and exercise.5. Benefits on Jalra-M on Long-term use:
Long-term use of Jalra-M 50/500 Tablet helps in maintaining consistent blood glucose levels, preventing spikes and crashes, which reduces the risk of diabetes-related complications like neuropathy and retinopathy. Over time, Jalra-M 50/500 Tablet may help improve lipid profiles (reducing triglycerides and LDL cholesterol), lowering the risk of heart disease, which is particularly beneficial for individuals with Type 2 Diabetes who are at higher cardiovascular risk.
How JALRA-M 50/500 MG TABLET Works
Jalra-M 50/500 Tablet combines two active ingredients: Vildagliptin and Metformin, which work together to help control blood sugar levels in people with Type 2 Diabetes.
How Jalra-M Controls Blood Sugar Levels:
- Vildagliptin stimulates the pancreas to release more insulin when blood sugar levels are high, especially after meals. It also helps to reduce the release of glucagon, a hormone that increases blood sugar. This combined effect helps keep blood glucose levels under control throughout the day.
- Metformin reduces the amount of sugar produced by the liver and decreases the absorption of sugar from food in the intestines. By working on both these fronts, it helps maintain stable blood sugar levels.
How Jalra-M Reduces Insulin Resistance:
- Metformin improves the body’s sensitivity to insulin, allowing the cells to better absorb glucose from the bloodstream. This helps the body use insulin more effectively and reduces insulin resistance, which is often a major issue in Type 2 Diabetes.
- Vildagliptin complements this action by helping the pancreas work more efficiently, further reducing the need for the body to produce excessive amounts of insulin. Together, they make the body's insulin more effective, addressing insulin resistance.
How Jalra-M Improves Overall Glycemic Control:
- The combination of Vildagliptin and Metformin offers dual-action: Metformin works to reduce glucose production and improve insulin sensitivity, while Vildagliptin boosts insulin secretion when needed and prevents excessive glucose production. This helps provide comprehensive control over blood sugar levels, improving overall glycemic control and reducing fluctuations in blood glucose.
By targeting different mechanisms in the body, Jalra-M helps individuals with Type 2 Diabetes manage their condition more effectively and maintain healthier blood sugar levels in the long term.
How to use JALRA-M 50/500 MG TABLET
Jalra-M 50/500 Tablet should be used as advised by your physician. Strictly follow the dosing schedule provided by your doctor for best results.
How to Use Jalra-M 50/500mg Tablet:
- Take Jalra-M 50/500mg Tablet with meals to help improve absorption and reduce stomach discomfort.
- Swallow the medicine with a glass of water. Do not chew or crush the tablet.
- It is important to take Jalra-M 50/500mg at the same time each day to help remember the dose and maintain stable blood sugar levels.
Recommended Dosage For Adults:
- Starting Dose: Typically, the starting dose of Jalra-M 50/500mg is one tablet once a day, taken with food, to reduce the risk of gastrointestinal side effects. The dosage may be adjusted by the healthcare provider depending on individual needs and response to the medication.
- Maximum Dose: The maximum recommended dose is two tablets (100mg/1000mg) daily, taken in divided doses (morning and evening), depending on your blood sugar levels and response to the medication.
Jalra-M Dosage Adjustments for Liver Disease Patients:
- Liver disease patients should use Jalra-M with caution. Dosage adjustments are necessary, and a lower dose of Metformin (500mg) should be considered, or the medication might be avoided altogether depending on the severity of liver function impairment. Close monitoring of liver function is recommended.
Jalra-M Dosage Adjustments for Heart Patients:
- Patients with heart conditions should use Jalra-M with care, especially if they have congestive heart failure or other cardiovascular issues. Dose adjustments may be necessary based on the individual’s health status and heart function, as Metformin can sometimes worsen heart failure symptoms. Consult a healthcare provider for personalized recommendations.
Jalra-M Dosage Adjustments for Kidney Patients:
- Kidney disease patients may require dose adjustments. In patients with moderate to severe renal impairment, Jalra-M should be avoided, or the dose should be reduced significantly, depending on kidney function. Kidney function must be regularly monitored during treatment.
Jalra-M Dosage Adjustments Based on Blood Sugar Levels:
- Dosage adjustments of Jalra-M are often made based on regular blood glucose monitoring. If blood sugar levels are not well controlled, your doctor may increase the dose or adjust the medication. Regular monitoring is crucial for maintaining appropriate blood sugar control.
Stopping Jalra-M Safely:
- Stopping Jalra-M should only be done under the guidance of your doctor. Abruptly stopping the medication may lead to poor blood sugar control. The doctor may gradually decrease the dosage to avoid complications and ensure blood glucose levels remain stable.
What if I forgot to take JALRA-M 50/500 MG TABLET
- If you forget to take a dose of Jalra-M 50/500mg Tablet, take it as soon as you remember, but if it's almost time for your next dose, skip the missed dose. Do not double the dose to make up for the missed dose.
Overdose
- In case of overdose, seek immediate medical attention. Symptoms of overdose may include severe low blood sugar (hypoglycemia), nausea, vomiting, dizziness, and weakness. The healthcare provider may initiate treatment to reverse the effects, which may include intravenous glucose or other emergency measures depending on the severity of the overdose.
Side Effects Of JALRA-M 50/500 MG TABLET
Like all medicines, Jalra-M may cause certain side effects in some individuals, although not everybody gets them.
Common Side Effects of Jalra-M Includes:
- Nausea, Vomiting
- Diarrhea, Indigestion, Abdominal pain or discomfort
- Constipation
- Headache, Dizziness
- Dyspepsia, heartburn, flatulence
- Taste disturbance
- Tiredness and loss of appetite
Side Effects in Liver Patients:
- Increased risk of lactic acidosis with Metformin.
- Liver dysfunction if not monitored properly
Side Effects in Kidney Patients:
- Higher risk of lactic acidosis due to Metformin accumulation.
- Reduced kidney function may affect Jalra-M’s effectiveness.
- Regular kidney function monitoring is essential.
When To Seek Medical Attention:
Stop taking Jalra-M 50/500 Tablet and contact your doctor immediately if you experience any of the following side effects:
- symptoms of lactic acidosis (such as vomiting, stomach pain, decreased heartbeat, difficulty breathing, muscle cramps, general weakness with severe tiredness, or reduced body temperature)
- signs of an inflamed pancreas (severe and persistent pain in the abdomen with or without nausea or vomiting)
Warning & Precautions

Pregnancy
RiskyThere is insufficient information regarding the use of Jalra-M 50/500 Tablet in pregnant women. Although, animal studies have not indicated any side effects on the growing baby, a risk to the growing baby cannot be excluded. Therefore, Jalra-M should not be used in pregnant women unless considered necessary by the physician. Your doctor may suggest insulin therapy for you during pregnancy.

Breastfeeding
ContraindicatedBoth Vildagliptin and Metformin have been shown to pass through breast milk. Therefore, the use of Jalra-M 50/500 Tablet should be avoided in breastfeeding women unless considered necessary by the physician.

Driving and Using Machines
Use with CautionDo not drive or operate any machines if you experience dizziness after taking this medicine.

Alcohol
Consult your doctorAvoid consumption of alcohol while taking Jalra-M as it may increase the risk of severe side effects like lactic acidosis.

Kidney
Consult your doctorJalra-M is not recommended in patients with severely reduced kidney function. It should be used with caution in patients with mild to moderate kidney problems. Proper dose adjustments and careful monitoring are required in such patients. Therefore, inform your doctor before taking Jalra-M if you have any pre-existing kidney problems as a precaution.

Liver
Consult your doctorJalra-M is not recommended for use in patients with severe liver diseases. It should be used with caution in patients with mild to moderate liver problems. Therefore, inform your doctor before taking Jalra-M, if you have any pre-existing liver conditions as a precaution.

Allergy
ContraindicatedDo not take this medicine if you are allergic (hypersensitive) to metformin or vildagliptin.

Heart Disease
ContraindicatedJalra M 50/500mg Tablet is not recommended in patients who recently had a heart attack or heart failure or any signs of heart problems such as serious blood circulation problems or difficulty breathing. Therefore, inform your doctor before taking this medicine.

Use In Pediatrics
ContraindicatedJalra M 50/500mg Tablet is not recommended for use in children and adolescents less than 18 years of age due to a lack of safety and effectiveness. Your doctor will decide whether it should be prescribed for your child or not based on your child’s health status.

Use In Geriatrics
Use with CautionJalra M 50/500mg Tablet should be used with caution in elderly patients above 65 years of age, especially in patients with impaired kidney function. Regular medical checkups and monitoring of liver, kidney and heart functions are necessary in such patients
Other Warnings for JALRA-M 50/500 MG TABLET
Before taking Jalra M 50/500mg Tablet, inform your doctor if you have or had:
- pancreatic disease
- Vitamin B12 deficiency
- Malnutrition with adrenal or pituitary insufficiency
Who should not take [GBNKEYWORD
Jalra M 50/500mg Tablet is not recommended for you if you have:
- Type 1 diabetes mellitus
- Uncontrolled diabetes
- Severe infection or seriously dehydrated
- are going to have a contrast x-ray (a specific type of x-ray involving an injectable dye)
Safety Advice
Expert Advice to Follow While Taking Jalra-M Tablet:
- Take with Food: Always take Jalra-M with meals to reduce stomach discomfort and help with better absorption.
- Monitor Blood Sugar: Regularly check your blood sugar levels to ensure the medication is working effectively.
- Stay Hydrated: Drink plenty of water to prevent dehydration, especially if you're prone to gastrointestinal issues.
- Avoid Alcohol: Limit alcohol intake as it can increase the risk of low blood sugar and other side effects.
- Consult Your Doctor Regularly: Keep your doctor informed about your progress and any side affects you may experience.
Diet and Lifestyle Advice
Best Foods to Eat For Diabetes Management:
- Focus on low glycemic index (GI) foods like leafy greens, whole grains, and lean proteins (chicken, fish).
- Include non-starchy vegetables (broccoli, cauliflower) and fruits (berries, apples) in moderation.
- Add healthy fats (avocado, nuts) and fiber-rich foods (beans, legumes) to improve blood sugar control.
- Limit sugary snacks and processed carbs to prevent spikes in glucose levels.
Exercise Routines to Manage Blood Sugar Levels:
- Aerobic exercises like walking, cycling, or swimming can help improve insulin sensitivity and reduce blood sugar levels.
- Incorporate strength training (using weights or resistance bands) at least twice a week to build muscle, which helps regulate glucose.
- Aim for at least 150 minutes of moderate-intensity exercise each week to maintain healthy blood sugar levels.
How to Monitor Blood Sugar at Home:
- Use a glucometer to check your blood sugar levels before and after meals to understand how your body reacts to different foods.
- Record your readings regularly to track patterns and share with your doctor for adjustments to your treatment plan.
- Continuous glucose monitoring (CGM) devices are available for more detailed tracking of your blood sugar throughout the day.
Synopsis
Drug | : | Metformin, Vildagliptin |
Pharmacological Category | : | Biguanides, Dipeptidyl peptidase 4 inhibitors |
Therapeutic Indication | : | Type II diabetes mellitus |
Dosage Forms | : | Tablet |
More Information
Jalra-M vs. Januvia 50/500 vs. Glucophage:
Aspect |
Jalra-M |
Januvia 50/500 |
Glucophage |
Active Ingredients |
Vildagliptin + Metformin |
Sitagliptin + Metformin |
Metformin |
Mechanism of Action |
Vildagliptin stimulates insulin release and reduces glucagon; Metformin decreases liver sugar production |
Sitagliptin increases insulin release and reduces glucagon; Metformin decreases liver sugar production |
Metformin decreases liver sugar production and enhances insulin sensitivity |
Indication |
Type 2 diabetes mellitus |
Type 2 diabetes mellitus |
Type 2 diabetes mellitus |
Side Effects |
Nausea, vomiting, diarrhea, dizziness |
Headache, upper respiratory infection, hypoglycemia |
Stomach upset, diarrhea, lactic acidosis (rare) |
FDA Approval |
Not FDA approved for combination |
FDA approved |
FDA approved |
Use in Pregnancy |
Not recommended |
Not recommended |
Caution, consult doctor |
Use in Kidney Impairment |
Dose adjustment required |
Dose adjustment required |
Dose adjustment required |
Use in Liver Impairment |
Caution, monitor liver function |
Caution, monitor liver function |
Caution, contraindicated in severe liver disease |
FAQs About JALRA-M 50/500 MG TABLET
Q: Can Jalra M 50/500 be taken during pregnancy?
A: Jalra-M 50/500 is not recommended during pregnancy due to potential risks to the unborn baby. It is important to discuss alternative treatments with your doctor to ensure the health and safety of both you and your baby.
Q: Is Jalra-M 50/500 Tablet a replacement for insulin?
A: Jalra-M 50/500 is not a replacement for insulin. It is an oral medication used to manage blood sugar in type 2 diabetes by improving insulin sensitivity and reducing glucose production in the liver. Insulin therapy may still be required for some patients to achieve optimal blood sugar control.
Q: Can it be used with insulin or other diabetic medications?
A: Yes, Jalra-M 50/500 can be used alongside insulin or other diabetic medications as prescribed by your healthcare provider. This combination can help optimize blood sugar control when used together with lifestyle changes such as diet and exercise.
Q: Can Jalra-M help with weight loss?
A: Jalra-M 50/500 may assist with modest weight loss in some individuals, especially by improving insulin resistance and lowering blood sugar levels, which can reduce the need for insulin production. However, it is not a weight loss medication and should be used in conjunction with a balanced diet and exercise.
Q: How does Jalra-M 50/500mg tablet help manage diabetes?
A: Jalra-M 50/500 works through a dual mechanism to help manage type 2 diabetes. Vildagliptin stimulates the pancreas to release insulin when blood sugar is high, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they help keep blood sugar levels stable.
Q: Is Jalra-M safe for long-term use?
A: Jalra-M 50/500 is generally safe for long-term use when prescribed by a doctor, especially when combined with proper monitoring of blood sugar, kidney function, and overall health. However, regular check-ups and blood tests are necessary to assess your body's response to the medication.
Q: What should I do if I missed a dose of Jalra-M 50/500 Tablet?
A: If you miss a dose of Jalra-M 50/500 tablet, take it as soon as you remember, unless it’s almost time for your next dose. Do not take two doses at once to make up for the missed dose. Consistency is key, so try to take the medication at the same time each day.
Q: Can I take Jalra-M on an empty stomach?
A: Jalra-M 50/500 tablet can be taken with or without food. However, taking it with food may help reduce any stomach discomfort or nausea, especially if you are sensitive to the medication.
Q: Is Jalra-M safe for people with kidney or liver issues?
A: Jalra-M 50/500 should be used with caution in patients with kidney or liver problems. Dose adjustments may be required, and kidney function should be monitored regularly. If you have severe kidney or liver disease, your doctor may recommend an alternative medication.
Q: Should I avoid alcohol while taking Jalra-M?
A: It is advisable to limit or avoid alcohol while taking Jalra-M 50/500, as alcohol can interfere with blood sugar control and increase the risk of side effects such as low blood sugar (hypoglycemia) or lactic acidosis.
Q: Can Jalra-M cause low blood sugar (hypoglycemia)?
A: Jalra-M 50/500 may cause low blood sugar (hypoglycemia) when used in combination with other diabetic medications like insulin or sulfonylureas. It is important to monitor your blood sugar levels and adjust your medication accordingly to prevent hypoglycemia.
Q: How long does it take for Jalra-M to work?
A: Jalra-M 50/500 may start to show improvements in blood sugar control within 1-2 weeks of use. However, it may take several weeks to achieve the desired blood glucose levels, depending on individual response and lifestyle factors.
Q: Does Jalra-M help with weight management in type 2 diabetes?
A: Jalra-M 50/500 can assist in weight management in type 2 diabetes by reducing insulin resistance and lowering blood sugar levels. This can help prevent weight gain often associated with diabetes medications, although weight loss is modest and should be complemented by a healthy diet and exercise.
Q: Can I use insulin with Jalra-M?
A: Yes, Jalra-M 50/500 can be used alongside insulin if your doctor prescribes it. Combining Jalra-M with insulin can help achieve better blood glucose control, especially when other medications alone are not sufficient.
Q: What is Jalra-M 50/500mg tablet used for?
A: Jalra-M 50/500 is used for the management of type 2 diabetes. It helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It is typically used when diet and exercise alone do not provide adequate blood sugar control.
Q: Can Jalra-M 50/500 help in lowering HbA1c levels?
A: Yes, Jalra-M 50/500 helps to lower HbA1c levels by improving insulin secretion, reducing glucose production in the liver, and enhancing insulin sensitivity, making it effective in long-term blood glucose control.
Q: Can Jalra-M help reduce the risk of heart disease in diabetics?
A: Jalra-M 50/500 may help reduce the risk of heart disease in diabetics by improving overall blood sugar control and reducing insulin resistance, which can contribute to cardiovascular problems if left unmanaged.
Q: Can I increase the dose of Jalra-M if my blood sugar is not controlled?
A: Jalra-M 50/500 should only be adjusted by your doctor. If your blood sugar is not controlled, your doctor may increase the dose or recommend additional medication or lifestyle changes to help achieve optimal blood glucose levels.
Q: Can I switch from Jalra-M to another diabetes medication?
A: Yes, you can switch from Jalra-M to another medication if it is not providing adequate blood sugar control or if you experience side effects. Consult your doctor for guidance on the most appropriate medication for your condition.
Q: Is it safe to switch from Jalra-M to insulin?
A: Yes, it is safe to switch from Jalra-M to insulin if your doctor determines that insulin therapy is needed for better blood sugar management. Your doctor will guide you on the appropriate timing and dosage when transitioning to insulin.
References
- Jalra-M. SajaPharma. Product Leaflet Summary. [Accessed on 31st January 2025].
- Jalra 50mg Tablet. Summary of Product Characteristics. [Accessed on 31st January 2025].
- Metformin + vildagliptin. Package Insert. [Accessed on 31st January 2025].
- Metformin + vildagliptin. Prescribing Information. [Accessed on 31st January 2025].
Useful Diagnostic Tests
- Random Blood Sugar (RBS)
- Fasting Blood Sugar (FBS)
- Post Prandial Blood Sugar (PPBS)
- Sugar Risk Package
- HbA1C, Also known as Glycated Hemoglobin, Glycosylated Hemoglobin
Some of the Best Glucometers Available in Netmeds:
Accu-Chek Active Glucose Monitor with Free 10 Test Strips
Dr. Morepen GlucoOne Blood Glucose Monitor (BG03) (Meter Only)
Accu-Chek Instant Glucometer with Free 10 Test Strips
Some Diabetic-Friendly Snack Available at Netmeds:
Pro360 Diabetic Care Powder - Real Badam Flavour 500 gm
Nestle Resource Diabetic Powder - Vanilla Flavour 400 gm (Pet Jar)
Pro360 Diabetic Care Protein Powder - Vanilla Flavour 500 gm